NeRRe Therapeutics

NeRRe Therapeutics

NeRRe Therapeutics

NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Founded
2012
Raised
$47M
Follow us
Alexa global traffic share
Latest funding
£23,000,000
Venture capital (Series B) - 2017
Fountain Healthcare Partners OrbiMed Novo A/S +2
$18,400,000
Venture capital (Series A) - 2012
Advent Venture Partners GlaxoSmithKline Novo A/S
Team Size
10+
Employees
$18,400,000 Venture capital (Series A)
stevenagecatalyst , biospace

Stevenage BioScience Catalyst | The Stevenage Voice - February 2013 |

£23,000,000 Venture capital (Series B)
PE Hub , GEN , pharmatimes

NeRRE Therapeutics picks up Series B funds